iTotal CR
-
Recon
Conformis iTotal® CR Knee Replacement System Awarded “5A” Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom
BILLERICA, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant…
Read More » -
Recon
ConforMIS Announces Clinical Study iTotal CR Customized Implants better approximate knee motion compared to Off-the-Shelf Total Knee Implant
BEDFORD, Mass., October 17, 2016 (GLOBE NEWSWIRE) – ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells…
Read More » -
Recon
Clinical Studies Demonstrate ConforMIS iTotal CR Customized Knee Implants Provide Superior Outcomes and Potential for Economic Savings
BEDFORD, Mass., August 15, 2016 (GLOBE NEWSWIRE) — ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells…
Read More » -
Extremities
ConforMIS Announces Results of Multiple Studies of its Customized Knee Replacements Presented at the 2015 Pan Pacific International Congress for Joint Reconstruction
Bedford, Mass., August 3, 2015 — ConforMIS, Inc. (NASDAQ: CFMS) announced today results from six clinical studies presented at the 2015…
Read More »